Certain Medical Programmers With Printed Circuit Boards, Components Thereof, and Products and Systems for Use With the Same; Notice of Commission Determination Not To Review an Initial Determination Terminating the Investigation in Its Entirety Based on Settlement; Termination of Investigation, 11328-11329 [2025-03525]
Download as PDF
<![CDATA[
11328
Federal Register / Vol. 90, No. 42 / Wednesday, March 5, 2025 / Notices
[Investigation Nos. 701–TA–608 and 731–
TA–1420 (Review)]
Steel Racks From China
Determinations
On the basis of the record 1 developed
in the subject five-year reviews, the
United States International Trade
Commission (‘‘Commission’’)
determines, pursuant to the Tariff Act of
1930 (‘‘the Act’’), that revocation of the
countervailing duty order and
antidumping duty order on steel racks
from China would be likely to lead to
continuation or recurrence of material
injury to an industry in the United
States within a reasonably foreseeable
time.
Background
The Commission instituted these
reviews on August 1, 2024 (89 FR
62779, August 1, 2024) and determined
on November 4, 2024, that it would
conduct expedited reviews (89 FR
96266, December 4, 2024).
The Commission made these
determinations pursuant to section
751(c) of the Act (19 U.S.C. 1675(c)). It
completed and filed its determinations
in these reviews on February 27, 2025.
The views of the Commission are
contained in USITC Publication 5593
(February 2025), entitled Steel Racks
from China: Investigation Nos. 701–TA–
608 and 731–TA–1420 (Review).
By order of the Commission.
Issued: February 27, 2025.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2025–03505 Filed 3–4–25; 8:45 am]
BILLING CODE 7020–02–P
INTERNATIONAL TRADE
COMMISSION
khammond on DSK9W7S144PROD with NOTICES
[Investigation No. 337–TA–1396]
Certain Medical Programmers With
Printed Circuit Boards, Components
Thereof, and Products and Systems for
Use With the Same; Notice of
Commission Determination Not To
Review an Initial Determination
Terminating the Investigation in Its
Entirety Based on Settlement;
Termination of Investigation
U.S. International Trade
Commission.
ACTION: Notice.
AGENCY:
1 The record is defined in § 207.2(f) of the
Commission’s Rules of Practice and Procedure (19
CFR 207.2(f)).
VerDate Sep<11>2014
16:51 Mar 04, 2025
Notice is hereby given that
the U.S. International Trade
Commission has determined not to
review an initial determination (‘‘ID’’)
(Order No. 30) of the presiding
administrative law judge (‘‘ALJ’’)
granting a joint motion of the
complainants and the respondent to
terminate the investigation based on
settlement. The investigation is
terminated.
FOR FURTHER INFORMATION CONTACT:
Richard P. Hadorn, Esq., Office of the
General Counsel, U.S. International
Trade Commission, 500 E Street SW,
Washington, DC 20436, telephone (202)
205–3179. Copies of non-confidential
documents filed in connection with this
investigation may be viewed on the
Commission’s electronic docket (EDIS)
at https://edis.usitc.gov. For help
accessing EDIS, please email
EDIS3Help@usitc.gov. General
information concerning the Commission
may also be obtained by accessing its
internet server at https://www.usitc.gov.
Hearing-impaired persons are advised
that information on this matter can be
obtained by contacting the
Commission’s TDD terminal, telephone
(202) 205–1810.
SUPPLEMENTARY INFORMATION: The
Commission instituted this investigation
on April 3, 2024, based on a complaint
filed by Medtronic, Inc., Medtronic
Logistics, LLC, and Medtronic USA,
Inc., all of Minneapolis, Minnesota, and
Medtronic Puerto Rico Operations Co. of
Juncos, Puerto Rico (collectively,
‘‘Medtronic’’). 89 FR 23043–44 (Apr. 3,
2024). The complaint, as supplemented,
alleges violations of section 337 of the
Tariff Act of 1930, as amended, 19
U.S.C. 1337, based on the importation
into the United States, the sale for
importation, and the sale within the
United States after importation of
certain medical programmers with
printed circuit boards, components
thereof, and products and systems for
use with the same by reason of the
infringement of certain claims of U.S.
Patent Nos. 8,712,540 (‘‘the ’540
patent’’) and 9,174,059 (‘‘the ’059
patent’’). Id. at 23043. The complaint
further alleges that a domestic industry
exists. Id. The notice of investigation
(‘‘NOI’’) names one respondent,
Axonics, Inc. (‘‘Axonics’’) of Irvine,
California. Id. at 23044. The Office of
Unfair Import Investigations (‘‘OUII’’) is
also named as a party. Id.
On August 12, 2024, the Commission
amended (i) the complaint to substitute
‘‘UNITED’’ in place of ‘‘MUNITED’’ on
the cover page and (ii) the NOI so that
the plain language description of the
accused products reads ‘‘sacral
SUMMARY:
INTERNATIONAL TRADE
COMMISSION
Jkt 265001
PO 00000
Frm 00080
Fmt 4703
Sfmt 4703
neuromodulation systems to control
neurostimulators surgically implanted
into a human patient, components
thereof, and medical programmers and
printed circuit boards used in same.’’
Order No. 11 (July 11, 2024),
unreviewed by 89 FR 66442 (Aug. 15,
2024).
On September 30, 2024, the
Commission terminated the
investigation as to (i) claim 17 of the
’540 patent and (ii) the ’059 patent in its
entirety based on Medtronic’s partial
withdrawal of the complaint. Order No.
16 (Sept. 9, 2024), unreviewed by
Comm’n Notice (Sept. 30, 2024).
On November 15, 2024, the
Commission terminated the
investigation as to claim 5, solely for the
purposes of infringement, and claims
11, 12, 14, 15, 18, 20, 39, and 40 of the
’540 patent based on Medtronic’s partial
withdrawal of the complaint. Order No.
21 (Oct. 31, 2024), unreviewed by
Comm’n Notice (Nov. 15, 2024).
On February 10, 2025, Medtronic and
Axonics filed a joint motion to
terminate the investigation in its
entirety based on a settlement
agreement, attaching thereto
confidential and non-confidential
versions of the subject agreement. OUII
did not file a response to the motion.
On February 11, 2025, the ALJ issued
Order No. 29, which (i) ordered
Medtronic and Axonics to ‘‘revise and
refile the non-confidential version of the
agreement required by Commission
Rules 210.21(a)(2) and 210.21(b)(1) [19
CFR 210.21(a)(2) and (b)(1)], and in
accordance with Commission Rule
201.6 [19 CFR 201.6],’’ and (ii) stated
that the motion to terminate will be
ruled upon after the revised nonconfidential version of the agreement is
refiled. Order No. 29 at 2 (Feb. 11,
2025). On February 18, 2025, Medtronic
and Axonics filed a revised nonconfidential version of the subject
agreement.
On February 19, 2025, the ALJ issued
the subject ID (Order No. 30) granting
the joint motion. The ID finds that, as
supplemented, the joint motion
complies with the requirements of
Commission Rule 210.21(b)(1), that
there are ‘‘no extraordinary
circumstances that warrant denying the
motion,’’ and that ‘‘there is no evidence
indicating that terminating this
investigation based on the settlement
agreement would be contrary to the
public interest.’’ No petitions for review
of the subject ID were filed.
The Commission has determined not
to review the subject ID. The
investigation is hereby terminated in its
entirety.
E:\FR\FM\05MRN1.SGM
05MRN1
11329
Federal Register / Vol. 90, No. 42 / Wednesday, March 5, 2025 / Notices
The Commission vote for this
determination took place on February
27, 2025.
The authority for the Commission’s
determination is contained in section
337 of the Tariff Act of 1930, as
amended (19 U.S.C. 1337), and in Part
210 of the Commission’s Rules of
Practice and Procedure (19 CFR part
210).
By order of the Commission.
Issued: February 27, 2025.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2025–03525 Filed 3–4–25; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
U.S. Marshals Service
[OMB Number 1105–0105]
Agency Information Collection
Activities; Proposed eCollection
eComments Requested; Extension
Without Change or a Currently
Approved Collection; Comments
Requested: Form CSO–005,
Preliminary Background Check Form
U.S. Marshals Service,
Department of Justice.
ACTION: 30-Day notice.
AGENCY:
The Department of Justice
(DOJ), U.S. Marshals Service (USMS),
will submit the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
DATES: Comments are encouraged and
will be accepted for 30 days until April
4, 2025.
FOR FURTHER INFORMATION CONTACT: If
you have additional comments,
particularly with respect to the
estimated public burden or associated
response time, have suggestions, need a
copy of the proposed information
collection instrument with instructions,
SUMMARY:
or desire any additional information,
please contact Assistant Chief Karl
Slazer/Management Support Division,
US Marshals Service Headquarters, 1215
S Clark St., Ste. 10017, Arlington, VA
22202–4387, by telephone at 703–740–
2316 or by email at karl.slazer@
usdoj.gov.
The
proposed information collection was
previously published in the Federal
Register on December 10, 2024, 89 FR
99281, allowing a 60-day comment
period. Written comments and
suggestions from the public and affected
agencies concerning the proposed
collection of information are
encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Evaluate whether and if so how the
quality, utility, and clarity of the
information to be collected can be
enhanced; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.
SUPPLEMENTARY INFORMATION:
Overview of This Information
Collection
1. Type of Information Collection
(check justification or form 83):
Extension without change or a currently
approved collection.
2. The Title of the Form/Collection:
Form CSO–005, Preliminary
Background Check Form.
3. The agency form number, if any,
and the applicable component of the
Department sponsoring the collection:
Form number (if applicable): Form
CSO–005.
Component: U.S. Marshals Service,
U.S. Department of Justice.
4. Affected public who will be asked
or required to respond, as well as a brief
abstract:
Primary: Court Security Officers/
Special Security Officer (CSO/SSO)
Applicants.
Other (if applicable): [None].
Abstract: The CSO–005 Preliminary
Background Check Form is used to
collect applicant information for CSO/
SSO positions. The applicant
information provided to USMS from the
Vendor gives information about which
District and Facility the applicant will
be working, the applicant’s personal
information, prior employment
verification, employment performance
and current financial status. The
information allows the selecting official
to hire applicants with a strong history
of employment performance and
financial responsibility. The questions
on this form have been developed from
the OPM, MSPB and DOJ ‘‘Best
Practice’’ guidelines for reference
checking.
5. An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: An estimated 750 respondents
will utilize the form, and it will take
each respondent approximately 60
minutes to complete the form.
6. An estimate of the total public
burden (in hours) associated with the
collection: The estimated annual public
burden associated with this collection is
750 hours, which is equal to (750 (total
# of annual responses) * 1 (60 mins).
7. An estimate of the total annual cost
burden associated with the collection, if
applicable:
TOTAL BURDEN HOURS
Number of
respondents
khammond on DSK9W7S144PROD with NOTICES
Activity
Frequency
Time per
response
(min.)
Total annual
responses
Total annual
burden
(hours)
Ex: Survey (individuals or households) ................
750
1/annually .....................
1,000
60
750
Unduplicated Totals .......................................
1,000
.......................................
1,000
........................
750
Estimated Total Annual Cost Burden:
$14,651.00.
If additional information is required
contact: Darwin Arceo, Department
Clearance Officer, United States
VerDate Sep<11>2014
16:51 Mar 04, 2025
Jkt 265001
Department of Justice, Justice
Management Division, Policy and
Planning Staff, Two Constitution
PO 00000
Frm 00081
Fmt 4703
Sfmt 4703
Square, 145 N Street NE, 4W–218,
Washington, DC.
E:\FR\FM\05MRN1.SGM
05MRN1
]]>Agencies
[Federal Register Volume 90, Number 42 (Wednesday, March 5, 2025)]
[Notices]
[Pages 11328-11329]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2025-03525]
-----------------------------------------------------------------------
INTERNATIONAL TRADE COMMISSION
[Investigation No. 337-TA-1396]
Certain Medical Programmers With Printed Circuit Boards,
Components Thereof, and Products and Systems for Use With the Same;
Notice of Commission Determination Not To Review an Initial
Determination Terminating the Investigation in Its Entirety Based on
Settlement; Termination of Investigation
AGENCY: U.S. International Trade Commission.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: Notice is hereby given that the U.S. International Trade
Commission has determined not to review an initial determination
(``ID'') (Order No. 30) of the presiding administrative law judge
(``ALJ'') granting a joint motion of the complainants and the
respondent to terminate the investigation based on settlement. The
investigation is terminated.
FOR FURTHER INFORMATION CONTACT: Richard P. Hadorn, Esq., Office of the
General Counsel, U.S. International Trade Commission, 500 E Street SW,
Washington, DC 20436, telephone (202) 205-3179. Copies of non-
confidential documents filed in connection with this investigation may
be viewed on the Commission's electronic docket (EDIS) at https://edis.usitc.gov. For help accessing EDIS, please email
[email protected]. General information concerning the Commission may
also be obtained by accessing its internet server at https://www.usitc.gov. Hearing-impaired persons are advised that information on
this matter can be obtained by contacting the Commission's TDD
terminal, telephone (202) 205-1810.
SUPPLEMENTARY INFORMATION: The Commission instituted this investigation
on April 3, 2024, based on a complaint filed by Medtronic, Inc.,
Medtronic Logistics, LLC, and Medtronic USA, Inc., all of Minneapolis,
Minnesota, and Medtronic Puerto Rico Operations Co. of Juncos, Puerto
Rico (collectively, ``Medtronic''). 89 FR 23043-44 (Apr. 3, 2024). The
complaint, as supplemented, alleges violations of section 337 of the
Tariff Act of 1930, as amended, 19 U.S.C. 1337, based on the
importation into the United States, the sale for importation, and the
sale within the United States after importation of certain medical
programmers with printed circuit boards, components thereof, and
products and systems for use with the same by reason of the
infringement of certain claims of U.S. Patent Nos. 8,712,540 (``the
'540 patent'') and 9,174,059 (``the '059 patent''). Id. at 23043. The
complaint further alleges that a domestic industry exists. Id. The
notice of investigation (``NOI'') names one respondent, Axonics, Inc.
(``Axonics'') of Irvine, California. Id. at 23044. The Office of Unfair
Import Investigations (``OUII'') is also named as a party. Id.
On August 12, 2024, the Commission amended (i) the complaint to
substitute ``UNITED'' in place of ``MUNITED'' on the cover page and
(ii) the NOI so that the plain language description of the accused
products reads ``sacral neuromodulation systems to control
neurostimulators surgically implanted into a human patient, components
thereof, and medical programmers and printed circuit boards used in
same.'' Order No. 11 (July 11, 2024), unreviewed by 89 FR 66442 (Aug.
15, 2024).
On September 30, 2024, the Commission terminated the investigation
as to (i) claim 17 of the '540 patent and (ii) the '059 patent in its
entirety based on Medtronic's partial withdrawal of the complaint.
Order No. 16 (Sept. 9, 2024), unreviewed by Comm'n Notice (Sept. 30,
2024).
On November 15, 2024, the Commission terminated the investigation
as to claim 5, solely for the purposes of infringement, and claims 11,
12, 14, 15, 18, 20, 39, and 40 of the '540 patent based on Medtronic's
partial withdrawal of the complaint. Order No. 21 (Oct. 31, 2024),
unreviewed by Comm'n Notice (Nov. 15, 2024).
On February 10, 2025, Medtronic and Axonics filed a joint motion to
terminate the investigation in its entirety based on a settlement
agreement, attaching thereto confidential and non-confidential versions
of the subject agreement. OUII did not file a response to the motion.
On February 11, 2025, the ALJ issued Order No. 29, which (i)
ordered Medtronic and Axonics to ``revise and refile the non-
confidential version of the agreement required by Commission Rules
210.21(a)(2) and 210.21(b)(1) [19 CFR 210.21(a)(2) and (b)(1)], and in
accordance with Commission Rule 201.6 [19 CFR 201.6],'' and (ii) stated
that the motion to terminate will be ruled upon after the revised non-
confidential version of the agreement is refiled. Order No. 29 at 2
(Feb. 11, 2025). On February 18, 2025, Medtronic and Axonics filed a
revised non-confidential version of the subject agreement.
On February 19, 2025, the ALJ issued the subject ID (Order No. 30)
granting the joint motion. The ID finds that, as supplemented, the
joint motion complies with the requirements of Commission Rule
210.21(b)(1), that there are ``no extraordinary circumstances that
warrant denying the motion,'' and that ``there is no evidence
indicating that terminating this investigation based on the settlement
agreement would be contrary to the public interest.'' No petitions for
review of the subject ID were filed.
The Commission has determined not to review the subject ID. The
investigation is hereby terminated in its entirety.
[[Page 11329]]
The Commission vote for this determination took place on February
27, 2025.
The authority for the Commission's determination is contained in
section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and
in Part 210 of the Commission's Rules of Practice and Procedure (19 CFR
part 210).
By order of the Commission.
Issued: February 27, 2025.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2025-03525 Filed 3-4-25; 8:45 am]
BILLING CODE 7020-02-P
